GCG and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: The authors have highlighted the importance of describing the population of SBS patients who are candidates to GLP-2 analogues to help centers to homogeneously select patients and to compare clinical practices around the world.